We are on an inspiring mission to embed sustainability into every aspect of our business, driving long-term growth and reinforcing our leadership in the medical sector. We are committed to reaching more patients while tackling critical issues such as climate change, resource scarcity, and human rights.
Sustainability runs through everything we do – from the materials that go into our products to the energy we use. Our goals focus on driving patient health and independence, reducing our ecological footprint, and ensuring responsible business practices.
By putting the patients, the environment, our employees, and the supply chain at the forefront, our 2030 Sustainability Strategy encompasses goals such as:
Our sustainability goals shape our 2030 Sustainability Strategy, a long-term vision with clear objectives and actionable steps. A key goal is to achieve 100% renewable energy use by 2030. Step by step, we are reducing greenhouse gas emissions across our entire value chain to create a more sustainable future.
Our 2030 Sustainability Strategy includes three key dimensions, creating a clear framework for concrete objectives and actions to be achieved by 2030.
Our self-care solutions empower patients to be more independent. It relieves them from time-consuming and expensive doctor visits.
Goal: By 2030, we will expand our portfolio by innovative and pioneering devices to improve patient outcomes and independence.
Target: >8M of patients enabled to be independent
Our commitment is to achieve a substantial reduction in greenhouse gas emissions across our value chain. This will be accompanied by the integration of circular design principles into new products, as well as the minimization of waste generated by our operations.
Goal: By 2030, we will significantly reduce GHG emissions, introduce circular principles, and reduce waste impact.
Targets by 2025:
Targets by by 2030:
We create an empowering work environment that promotes diversity, equity, and inclusion, while ensuring the health and safety of our employees.
Goal: By 2030, we will manifest a sustainable business
foundation for our people and supply chain. To establish this, we set clear goals and define precise actions.
Targets by 2025:
Targets by 2030:
In 2023, we were awarded the Ecovadis Silver medal. The result ranks SHL Medical in the top 8% in its industry, “manufacture of medical and dental instruments and supplies”, and in the top 25% of all companies globally.
The Science Based Targets initiative (SBTi) has approved SHL Medical’s near-term science-based emissions reduction target. The independent verification of SHL’s ambitious 2030 goals also acknowledges the company’s contribution to limiting global warming to 1.5°C.
SHL Medical has officially joined the United Nations Global Compact (UNGC). This partnership aligns with the company’s ambitious 2030 goals, emphasizing its dedication to upholding universal sustainability principles on human rights, labor, environment, and anti-corruption.
SHL Medical contributes to the UN’s 17 Sustainability and Development Goals (SDGs). By concurrently aligning the sustainability strategy while actively engaging with the UNGC, we have sharpened our focus on our key SDGs: good health and wellbeing, affordable and clean energy, decent work and economic growth, responsible consumption and production, and climate action.
Our 2023 sustainability report details the company’s ongoing efforts and accomplishments in sustainability and innovation. The publication of this report marks another milestone in the company’s journey toward transparency, accountability, and continuous improvement.
The 2023 sustainability report highlights our progress and achievements and reaffirms our commitment to making a positive social and environmental impact while advancing the development of innovative self-injection solutions.”
Our sustainable business model thrives on collaboration with both upstream and downstream partners.
In her interview with ONdrugDelivery magazine, SHL Medical Head of Sustainability, Dora Rio, delves into our approach to sustainable practices. She underscores SHL’s responsibility as a device designer and manufacturer to drive industry-wide adoption of circular strategies. Addressing the reusable vs. single-use device dilemma, Dora emphasizes SHL’s commitment to tailor our designs to meet specific treatment requirements and patient needs. Our ultimate mission? To foster a sustainable business environment through eco-friendly products and processes.
